United States RSV Therapeutics Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The Global Respiratory Syncytial Virus (RSV) Therapeutics Market reached USD 1.2 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 2.4 billion by 2030. The market is expected to exhibit a CAGR of 10.2% during the forecast period (2024-2031).

Recent Mergers and Acquisitions & Key Development:

United States: Recent RSV Therapeutics Developments

✅ In July 2025, Sanofi acquired Vicebio for $1.6 billion to expand its respiratory vaccines pipeline. The acquisition includes a combination vaccine candidate for RSV and human metapneumovirus, currently in Phase 1.

✅ In June 2025, Merck's RSV monoclonal antibody, ENFLONSIATM (clesrovimab-cfor), received FDA approval for the prevention of lower respiratory tract disease caused by RSV in infants. Shipments are expected before the 2025-2026 RSV season.

✅ In May 2025, Sanofi announced that an immunization program using Beyfortus reduced infant hospitalizations due to RSV by 69% during the 2024-2025 RSV season compared to the previous season.

Japan: Recent RSV Therapeutics Developments

✅ In July 2025, GSK's RSV vaccine, Arexvy, received regulatory approval from Japan's Ministry of Health, Labour and Welfare for adults aged 50-59 at increased risk of severe RSV disease.

✅ In July 2025, Invivyd raised $57.5 million to advance its monoclonal antibody pipeline targeting RSV, measles, and Long COVID. The company aims to identify a best-in-class RSV monoclonal antibody candidate by Q3 2025.

✅ In May 2025, Sanofi's Beyfortus was approved for use in Japan, aiming to protect infants from RSV.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/respiratory-syncytial-virus-therapeutics-market?sb

Respiratory Syncytial Virus (RSV) Therapeutics are treatments aimed at preventing or managing RSV infections, which primarily affect the respiratory tract in infants, young children, and older adults. They include antiviral drugs, monoclonal antibodies, and supportive care therapies that reduce severity, prevent complications, and improve patient outcomes.

Key Players:

-> Sanofi, GSK plc, Pfizer, AstraZeneca, AbbVie, Bausch Health Companies, Bavarian Nordic, Merck & Co, Moderna, Inc., and mAbxience, among others.

Growth Forecast Projected:

The Global Aerial Imaging Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Aerial Imaging Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=respiratory-syncytial-virus-therapeutics-market

Key Segments:

➥ By Drug Type: Ribavirin, Nirsevimab, Virazole, Palivizumab, Riba Tab, Others
➥ By Dosage Form: Oral, Injectable, Inhaler, Others
➥ By Treatment Type: Immune Prophylaxis, Supportive Care, Antiviral Medications
➥ By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Regional Analysis for Aerial Imaging Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Aerial Imaging producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Aerial Imaging revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/respiratory-syncytial-virus-therapeutics-market?sb

FAQ

What is the current size of the Aerial Imaging Market?

A: In 2022, the Aerial Imaging Market was valued at USD 1.2 billion, reflecting its strong industry presence.

Q2: How large is the Aerial Imaging Market expected to be by 2030?

A: By 2030, industry forecasts suggest the Aerial Imaging Market will grow to around USD 2.4 billion , demonstrating significant expansion.

Q3: What is the growth rate of the Aerial Imaging Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 10.2% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.